Trials / Recruiting
RecruitingNCT07147218
Accelerated TMS for MDD
Accelerated Transcranial Magnetic Stimulation for Major Depressive Disorder
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Neuronetics · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Detailed description
This protocol will investigate the feasibility, tolerability and clinical efficacy of an accelerated TMS protocol delivering 36 sessions in 5 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TMS | transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days |
Timeline
- Start date
- 2025-08-21
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2025-08-29
- Last updated
- 2025-11-21
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07147218. Inclusion in this directory is not an endorsement.